Rural Health
Resources by Topic: Prescription drug misuse
Indigenous Evaluation Toolkit: An Actionable Guide for Organizations Serving American Indian/Alaska Native Communities through Opioid Prevention Programming
Toolkit presents guidance for American Indian and Alaska Native communities and organizations for providing opioid prevention services. Provides a four-phase plan for program design and details holistic and culturally competent approaches to opioid prevention.
Author(s): Danielle Eakins, Angela Gaffney, Caelin Marum, et al.
Date: 02/2023
Type: Document
Sponsoring organization: Seven Directions - A Center for Indigenous Public Health
view details
Toolkit presents guidance for American Indian and Alaska Native communities and organizations for providing opioid prevention services. Provides a four-phase plan for program design and details holistic and culturally competent approaches to opioid prevention.
Author(s): Danielle Eakins, Angela Gaffney, Caelin Marum, et al.
Date: 02/2023
Type: Document
Sponsoring organization: Seven Directions - A Center for Indigenous Public Health
view details
Over the Hills and Through the Hollers: How One Program is Assisting Residents of Appalachia with Opioid Use Recovery
Results of a study evaluating the Kentucky Access to Recovery Program (KATR), which provides services to low-income adults recovering from opioid addiction in several rural eastern Kentucky counties. Examines the impact of KATR on service recipients' access to recovery services and supports.
Author(s): Aubrey E. Jones, Jayme E. Walters, Aaron R. Brown
Citation: Journal of Appalachian Health, 4(3), 71-86
Date: 01/2023
Type: Document
view details
Results of a study evaluating the Kentucky Access to Recovery Program (KATR), which provides services to low-income adults recovering from opioid addiction in several rural eastern Kentucky counties. Examines the impact of KATR on service recipients' access to recovery services and supports.
Author(s): Aubrey E. Jones, Jayme E. Walters, Aaron R. Brown
Citation: Journal of Appalachian Health, 4(3), 71-86
Date: 01/2023
Type: Document
view details
I Don't Believe a Person Has to Die When Trying to Get High: Overdose Prevention and Response Strategies in Rural Illinois
Examines overdose prevention and response of service providers and people who inject drugs in rural southern Illinois. Reports on interviews with 23 participants from August 2019 through February 2020 and discusses issues such as the growing presence of fentanyl, overdose prevention, overdose reversal, harm reduction education, and more.
Author(s): Suzan M. Walters, Marisa Felsher, David Frank, et al.
Citation: International Journal of Environmental Research and Public Health, 20(2), 1648
Date: 01/2023
Type: Document
view details
Examines overdose prevention and response of service providers and people who inject drugs in rural southern Illinois. Reports on interviews with 23 participants from August 2019 through February 2020 and discusses issues such as the growing presence of fentanyl, overdose prevention, overdose reversal, harm reduction education, and more.
Author(s): Suzan M. Walters, Marisa Felsher, David Frank, et al.
Citation: International Journal of Environmental Research and Public Health, 20(2), 1648
Date: 01/2023
Type: Document
view details
Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic
Details a study evaluating the rates of buprenorphine-involved overdose deaths before the COVID-19 pandemic and during the pandemic when prescribing regulations were loosened. Compares overdose mortality rates involving buprenorphine in 2019 and 2021 and breaks down data by a number of demographic factors, including rural versus urban location.
Author(s): Lauren J. Tanz, Christopher M. Jones, Nicole L. Davis, et al.
Citation: JAMA Network Open, 6(1), e2251856
Date: 01/2023
Type: Document
view details
Details a study evaluating the rates of buprenorphine-involved overdose deaths before the COVID-19 pandemic and during the pandemic when prescribing regulations were loosened. Compares overdose mortality rates involving buprenorphine in 2019 and 2021 and breaks down data by a number of demographic factors, including rural versus urban location.
Author(s): Lauren J. Tanz, Christopher M. Jones, Nicole L. Davis, et al.
Citation: JAMA Network Open, 6(1), e2251856
Date: 01/2023
Type: Document
view details
2020 Rural Opioid Overdose Mortality
Highlights the rate of rural opioid overdose mortality in 2020 for several northern New England states and compares it to the national rate. Breaks down rates based on substances used as well.
Date: 01/2023
Type: Document
Sponsoring organization: University of Vermont Center on Rural Addiction
view details
Highlights the rate of rural opioid overdose mortality in 2020 for several northern New England states and compares it to the national rate. Breaks down rates based on substances used as well.
Date: 01/2023
Type: Document
Sponsoring organization: University of Vermont Center on Rural Addiction
view details
Opioid Overdose Surveillance Preliminary District Report: Georgia, 2021
Describes district level fatal and nonfatal opioid-involved overdoses that occurred in Georgia from 2019-2021, including prescription opioids and illicit opioids including heroin, fentanyl, and fentanyl analogs. Features statistics on demographics, overdose deaths, and emergency department visits, with breakdowns by district, drug type, and year.
Date: 12/2022
Type: Document
Sponsoring organization: Georgia Department of Public Health
view details
Describes district level fatal and nonfatal opioid-involved overdoses that occurred in Georgia from 2019-2021, including prescription opioids and illicit opioids including heroin, fentanyl, and fentanyl analogs. Features statistics on demographics, overdose deaths, and emergency department visits, with breakdowns by district, drug type, and year.
Date: 12/2022
Type: Document
Sponsoring organization: Georgia Department of Public Health
view details
Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines
Report examines the changes in access to buprenorphine following the implementation of new HHS guidelines as of April 2021. Discusses the revised guidelines and analyzes their effect on access to buprenorphine for patients with opioid use disorder.
Date: 12/2022
Type: Document
Sponsoring organization: U.S. Department of Health and Human Services
view details
Report examines the changes in access to buprenorphine following the implementation of new HHS guidelines as of April 2021. Discusses the revised guidelines and analyzes their effect on access to buprenorphine for patients with opioid use disorder.
Date: 12/2022
Type: Document
Sponsoring organization: U.S. Department of Health and Human Services
view details
Impact of Mandatory COVID-19 Shelter-in-Place Order on Controlled Substance Use Among Rural Versus Urban Communities in the United States
Features a study on the effect the shelter-in-place orders during the COVID-19 pandemic had on uses of controlled substances, such as methamphetamine, opioids, and cocaine, among others. Draws data from calls made to poison control centers from October of 2019 to July of 2020 and compares rates of calls by rural versus urban locations.
Author(s): Daniel Maeng, Yue Li, Michele Lawrence, et al.
Citation: Journal of Rural Health, 39(1), 21-29
Date: 12/2022
Type: Document
view details
Features a study on the effect the shelter-in-place orders during the COVID-19 pandemic had on uses of controlled substances, such as methamphetamine, opioids, and cocaine, among others. Draws data from calls made to poison control centers from October of 2019 to July of 2020 and compares rates of calls by rural versus urban locations.
Author(s): Daniel Maeng, Yue Li, Michele Lawrence, et al.
Citation: Journal of Rural Health, 39(1), 21-29
Date: 12/2022
Type: Document
view details
Changes in Transmucosal Buprenorphine Utilization for Opioid Use Disorder Treatment During the COVID-19 Pandemic in Kentucky
Explores changes in prescription rates of transmuscosal buprenorphine for the treatment of opioid use disorder during the COVID-19 pandemic in Kentucky. Compares prescribing rates in rural versus urban areas and examines rates on a week by week basis.
Author(s): Feitong Lei, Michelle R. Lofwall, Patricia R. Freeman, et al.
Citation: Journal of Rural Health, 39(1), 186-196
Date: 12/2022
Type: Document
view details
Explores changes in prescription rates of transmuscosal buprenorphine for the treatment of opioid use disorder during the COVID-19 pandemic in Kentucky. Compares prescribing rates in rural versus urban areas and examines rates on a week by week basis.
Author(s): Feitong Lei, Michelle R. Lofwall, Patricia R. Freeman, et al.
Citation: Journal of Rural Health, 39(1), 186-196
Date: 12/2022
Type: Document
view details
Appalachian Diseases of Despair
Uses data from the 2020 Multiple Cause of Death database to provide information on mortality from overdose, suicide, and alcoholic liver disease/cirrhosis among people ages 15-64. Includes data and statistics, with information broken down by Appalachian state, region, gender, and metropolitan or nonmetropolitan status.
Date: 11/2022
Type: Document
Sponsoring organizations: Appalachian Regional Commission, East Tennessee State University Center for Rural Health Research, NORC Walsh Center for Rural Health Analysis
view details
Uses data from the 2020 Multiple Cause of Death database to provide information on mortality from overdose, suicide, and alcoholic liver disease/cirrhosis among people ages 15-64. Includes data and statistics, with information broken down by Appalachian state, region, gender, and metropolitan or nonmetropolitan status.
Date: 11/2022
Type: Document
Sponsoring organizations: Appalachian Regional Commission, East Tennessee State University Center for Rural Health Research, NORC Walsh Center for Rural Health Analysis
view details